Vandetanib Intermediates CAS NO 264208-72-2 Pharmaceutical Intermediates

1. Pharmacological Efficacy: This compound has demonstrated remarkable biological activity, making it an essential ingredient in various therapeutic formulations.

2. Customizable formulations: Due to its versatility, 4-chloro-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline can be easily integrated into different pharmaceutical formulations, including tablets, capsules, and injections.

3. Regulatory Compliance: Our manufacturing processes adhere to strict regulatory standards, ensuring our products meet the highest quality and safety requirements for pharmaceutical use.

4. R&D Support: We provide comprehensive support for R&D programs to assist our customers in optimizing formulations and achieving desired results.

4-Chloro-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline is primarily used to develop pharmaceuticals for various health conditions. Its unique properties make it suitable for the synthesis of APIs and intermediates. The compound shows promise in areas such as oncology, pain management, and neurological disorders, making it a valuable asset in drug formulations.

As a manufacturer and trader, we are proud to provide high quality compounds to our customers in the pharmaceutical industry. Our commitment to excellence is reflected in our state-of-the-art manufacturing facilities, which are equipped with advanced technology and operated by a skilled workforce. We understand the importance of timely delivery and competitive pricing, and we strive to exceed our customers' expectations in every aspect of our service.

 4-Chloro-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline is a crystalline solid with the molecular formula C16H20ClN3O2. Its molecular weight is 321.80 g/mol. The compound is usually a white to off-white powder with good solubility in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, which facilitates its incorporation into pharmaceutical formulations.

 The compound has a melting point of approximately 150-155°C, indicating that it is thermally stable, which is essential for maintaining efficacy during storage and processing. Its chemical structure has chlorine groups and methoxy groups, which enhance its pharmacological properties and make it a valuable component in the synthesis of active pharmaceutical ingredients (APIs).

 In summary, 4-chloro-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline is an important compound for the pharmaceutical industry, offering numerous advantages for drug formulation and development. With our expertise in synthesis and commitment to quality, we are a trusted partner for all your chemistry needs. Contact us today to learn more about our products and how we can support your pharmaceutical business.